Rallis India Q1 FY27: Revenue Up 7% to ₹1,022 Cr, EBITDA Surges 23%
Rallis India reported Q1 FY27 revenue of ₹1,022 crore, a 7% increase YoY. EBITDA surged 23% to ₹184 crore, and PAT grew 31% to ₹125 crore. The company launched 3 new products and saw strong B2C growth.
The positive financial results and strategic initiatives like new product launches are beneficial, but the overall market conditions and specific segment performances suggest a moderate impact.
The company reported positive financial results with revenue and profit growth, alongside new product launches, indicating a favorable performance despite market challenges.
Rallis India Limited has submitted an investor presentation detailing its financial results for the quarter ended June 30, 2026. The presentation was made available following an analysts/investors call held on Tuesday, July 21, 2026.
The company reported a resilient performance despite a challenging environment. Revenue for the quarter increased by 7% to ₹1,022 crore, driven by strong placement and campaign activities in the domestic formulation business. EBITDA saw a significant jump of 23% to ₹184 crore, primarily attributed to better volume growth in Crop Protection and cost optimization. Profit After Tax (PAT) after exceptional items rose by 31% to ₹125 crore.
Key business highlights include a 19% revenue growth in the B2C business, overcoming industry challenges such as a delayed monsoon and crop shifts. The company launched three new products during the quarter: two herbicides and one insecticide. The B2B business experienced higher unit margins and strong demand for certain international products, while the Custom Synthesis Manufacturing (CSM) business saw a volume uptick in select products.
The Soil & Plant Health business registered volume growth through pre-placement, and the Seeds business, despite market headwinds from delayed sowings, launched nine new products across Cotton, Millet, and Paddy. The company emphasized its vision of serving farmers through science and its integrated business model spanning R&D, manufacturing, and distribution.
Operational context highlighted subdued overall demand due to the driest June in 12 years, delayed Kharif sowings, and crop shifts, compounded by geopolitical factors impacting commodity prices. Despite these challenges, Rallis India focused on aggressive pre-placement and liquidation efforts, digital marketing interventions, and the launch of new products across its Crop Protection and Seeds segments.
What to do with a filing like this
Rallis India Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rallis India Limited. Read the original for the full detail.